4 Th Hematology Lecture

Embed Size (px)

Citation preview

  • 8/8/2019 4 Th Hematology Lecture

    1/13

    Dr. Doaa A. Ghareeb, Ph.D.

  • 8/8/2019 4 Th Hematology Lecture

    2/13

    Normal Values Adults (Wintergreen method): Men under 50 yearsold:lessthan 15 mm/hr. (7 and 17)

    Men over 50 yearsold:lessthan 20 mm/hr.

    Women under 50 yearsold:lessthan 20 mm/hr.

    Women over 50 yearsold:lessthan 30 mm/hr.

    Children (Westergren method): Newborn: 0 to 2 mm/hr.

    Neonatalto puberty: 3 to 13 mm/hr.

    It isonly usefulfor diagnosing threediseases:myeloma, temporalarteritis and polymyalgiarheumatica (in which it may exceed 100mm/hour).

  • 8/8/2019 4 Th Hematology Lecture

    3/13

    C-reactive protein (CRP) isa plasma protein.

    CRP isa member ofthe classofacute phase

    protein producedby theliver as itslevels

    risedramatically during inflammatoryprocessesoccurring in thebody.

    It isthoughttoassist in complementbinding

    toforeign anddamaged cellsandenhances

    phagocytosis. CRP isused mainly asa marker of

    inflammation.

  • 8/8/2019 4 Th Hematology Lecture

    4/13

    Coagulation isa complex processby whichblood

    formssolid clots.

    isordersof coagulation can leadtoan increased

    risk ofbleeding and/or clotting. Coagulation involvesbotha cellular (platelet)

    anda protein (coagulation factor) component.

    Coagulation time Thetime requiredfor bloodto

    coagulate in a glasstube prolonged in haemophiliaand in the presenceof

    obstructive jaundice, someanaemiasand

    leukaemias, andsomeofthe infectiousdiseases.

  • 8/8/2019 4 Th Hematology Lecture

    5/13

    Bleeding time isa medicaltestdoneon someonetoassesstheir plateletfunction.

    iseasesthat cause prolongedbleeding time includethrombocytopeniaanddisseminated intravascularcoagulation ( IC).

    Aspirin andother cyclooxygenase inhibitors can prolongbleeding timesignificantly.

    Whilewarfarin andheparin havetheir major effectson

    coagulation factors, an increasedbleeding time issometimesseen withuseofthese medicationsaswell. Normalvaluesfallbetween 2 - 9 minutesdepending on

    the methodused.Alancetor scalpelblade isusedto makeastabwoundon

    theundersideoftheforearm.

    Thetimefrom when thestabwound is madeuntilallbleeding hasstopped is measuredand is calledthebleeding time.

    Every 30 seconds, filter paper or a paper towel isusedtodrawofftheblood.

    Thetest isfinishedwhen bleeding hasstopped completely.

  • 8/8/2019 4 Th Hematology Lecture

    6/13

    It is measuredasthetimefor clotformationafter exogenousthrombin isaddedto citratedplasma.

    Uses:

    Therapeutic leveloftheanticoagulant Heparin.

    etecting the presenceofafibrinogen abnormality

    Procedure:

    1 part blood + 9 part citrate or oxalate

    centrifugation plasmaPlasma + thrombin reagent clot

    formation time

    TTor TCT isthetimebetween theaddition ofthethrombin andthe clotformation is recorded

    asthethrombin clotting time

  • 8/8/2019 4 Th Hematology Lecture

    7/13

    Referencevalue:

    Lessthan 21 seconds.

    Abnormalvalue:

    heparin therapy

    Hypofibrinogenemia

    fibrinogen abnormality

    Lupusanticoagulant

  • 8/8/2019 4 Th Hematology Lecture

    8/13

    The prothrombin time isthetime ittakesplasmato clotafter addition oftissuefactor.

    Or the rateatwhich prothrombin isconvertedtothrombin in citratedbloodwithadded calcium

    measuresofthequality extrinsic pathwayofcoagulation.

    PT measuresfactorsII, V, VII, X andfibrinogen

    The prothrombin ratio The prothrombin ratio isthe prothrombin timefor a

    patient, dividedby the resultfor control plasma.

    reference range:12-15 seconds

  • 8/8/2019 4 Th Hematology Lecture

    9/13

    Lowlevelsofblood proteins (blood clottingfactors).

    ecrease in activity ofany ofthefactors.

    T

    heabsenceofany ofthefactors Deficiencies in vitamin K, which can be caused

    by warfarin, malabsorption or lack of intestinalcolonization by bacteria (suchas in newborns).

    The presenceofasubstancethatblocksthe

    activity ofany ofthefactors An abnormal prothrombin time isoften caused

    by liver diseaseor injury or by treatmentwiththe medication warfarin, which isusedtopreventtheformation ofblood clots.

  • 8/8/2019 4 Th Hematology Lecture

    10/13

    Medicationsthat can affecttheaction ofblood-thinners (suchaswarfarin)andvitamin K, which in turn affectsthePT result,including antibiotics, aspirin, cimetidine (Tagamet),barbiturates, birth control pills, hormone replacementtherapy(HRT), andvitamin K supplements

    Severediarrheaor vomiting that causesfluidlossanddehydration, which may increase prothrombin time.

    Ifdiarrhea is causedby poor absorption of nutrients, vitamins,and mineralsfrom the intestinaltract (malabsorptionsyndrome), PT may increasebecauseofavitamin K deficiency

    Foodsthat contain vitamin K, suchasbeefliver, pork liver,

    green tea, broccoli, andsoybean products Excessiveuseofalcohol

    Laxatives

    Someherbal productsor natural remedies

    Somelaboratoriesusea mechanical measurement, whicheliminates interferencesfrom lipemic and icteric samples.

  • 8/8/2019 4 Th Hematology Lecture

    11/13

    or activated partialthromboplastin time

    (aPTTor APTT) isa performance indicator

    measuring theefficacy ofboththe "intrinsic"

    andthe common coagulation pathways.Normal values and interpretation

    Normalvalues may vary from labtolab.

    Partial thromboplastin time (PTT): 3045 seconds

  • 8/8/2019 4 Th Hematology Lecture

    12/13

    Deficiency or abnormality ofoneofthebloodclotting factorsor another substance neededtoclotblood. Adeficiency ofoneor moreofthesefactors results in ableeding disorder (suchashemophilia).

    liver disease, kidney disease, or treatmentwithmedicationssuchasheparin or warfarin(Coumadin)thatareusedto preventtheformation ofblood clots.

    Antiphospholipid antibody syndromeandlupusanticoagulantsyndromethat can causeabnormalclotting or blood clotformation.

    Useofaspirin during heparin therapy, sothePTTvalue needstobe closely monitored

  • 8/8/2019 4 Th Hematology Lecture

    13/13

    Thank You For YourThank You For Your

    AttentionAttention